Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9

被引：0
|
作者：
Bai, Jinmeng [1 ,2 ]
Zhang, Jianchao [1 ,2 ]
Fu, Wanrong [1 ,2 ]
Li, Shuang [1 ,2 ]
Tian, Xiaoxu [1 ,2 ]
Li, Xiaowei [1 ,2 ]
Zhao, Xiaoyan [1 ,2 ]
Dong, Jianzeng [1 ,2 ,3 ]
机构：
[1] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Henan Key Lab Hereditary Cardiovasc Dis, Zhengzhou 450052, Peoples R China
[3] Capital Med Univ, Beijing Anzhen Hosp, Natl Clin Res Ctr Cardiovasc Dis, Dept Cardiol, 2 Beijing Anzhen Rd, Beijing 100029, Peoples R China
来源：
STEM CELL RESEARCH | 2023年 / 67卷
关键词：
D O I：
10.1016/j.scr.2023.103040
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The transient receptor potential cation channel subfamily M member 8 (TRPM8) is a kind of non-selective cation channel which controls Ca2+ homeostasis. Mutations in TRPM8 were related to dry eye diseases (DED). Here we constructed a TRPM8 knockout cell line WAe009-A-A from the original embryonic stem cell line H9 using CRISPR/Cas9 technology, which maybe helpful for exploring the pathogenesis of DED. WAe009-A-A cells possess stem cell morphology and pluripotency as well as normal karyotype, and have the ability of differentiating into three germ layers in vitro.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9
    Sun, Wenrui
    Li, Xiaowei
    Dong, Jianzeng
    Zhou, Yangfan
    STEM CELL RESEARCH, 2024, 74
  • [2] Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9
    Lu, Fengyuan
    Gao, Yifeng
    Li, En
    STEM CELL RESEARCH, 2023, 71
  • [3] Generation of ID1/3 knockout human embryonic stem cell lines (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9
    Li, Yihui
    Du, Mingxia
    Jin, Zibing
    STEM CELL RESEARCH, 2024, 81
  • [4] A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy
    Qin, Zhiping
    Sun, Liqiang
    Sun, Xue
    Su, Hang
    Gao, Xinxuan
    STEM CELL RESEARCH, 2021, 56
  • [5] Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9
    Cao, Yuhong
    Tang, Ling
    Su, Jun
    Wang, Hao
    Liang, Ping
    Rong, Kuang
    Gong, Tingyu
    STEM CELL RESEARCH, 2023, 72
  • [6] Generation of a homozygous CRISPR/Cas9-mediated knockout H9 hESC subline for the MERTK locus
    Tang, Xiangcheng
    Fu, Jialing
    Chen, Zhigang
    Luo, Lixia
    Li, David Wan-Cheng
    Liu, Yizhi
    STEM CELL RESEARCH, 2021, 53
  • [7] Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9
    Seo, Hyang-Hee
    Han, Hyo-Won
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2020, 45
  • [8] Generation of SHMT2 knockout human embryonic stem cell line (WAe009-A-67) using CRISPR/Cas9 technique
    Li, Jisheng
    Zhang, Bowen
    Gan, Min
    Li, Yunxing
    He, Lijuan
    Yue, Wen
    Qiao, Haixuan
    Pei, Xuetao
    Li, Yanhua
    STEM CELL RESEARCH, 2021, 57
  • [9] Generation of a homozygous CPAMD8 knockout human embryonic stem cell line (WAe009-A-2R) by CRISPR/Cas9 system
    Pan, Wenmin
    Yang, Yuhe
    Zhang, Shun
    Liu, Xiaoyu
    Hu, Huijuan
    Qu, Jia
    Liu, Hui
    STEM CELL RESEARCH, 2025, 84
  • [10] Generation of a homozygous CRISPR/Cas9-mediated knockout H9 hESC subline for the CRB1 locus
    Tang, Xiangcheng
    Chen, Zhigang
    Tan, Xuhua
    Luo, Lixia
    Liu, Xialin
    Gong, Lili
    Li, David Wan-Cheng
    Liu, Yizhi
    STEM CELL RESEARCH, 2020, 49
12345